Over the past five years, the Siteman team has been active in sharing its clinical experience to advance the practice of MRI-guided radiation therapy. Clinicians from Siteman have presented more than 90 papers and posters at major medical meetings and published more than 40 studies in peer-reviewed medical journals, highlighting their experience with MRI-guided radiation therapy. The department is currently involved in four clinical trials to explore MRI-guided radiation therapy for pancreas, breast, lung, and spine. To date, the MRIdian system at Siteman Cancer Center has been used to treat more than 890 patients, 2,200 adaptive therapy sessions and more than 15 different indications.
About ViewRay
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
SOURCE ViewRay, Inc.
Back to HCB News
